Profile data is unavailable for this security.
About the company
Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.
- Revenue in HKD (TTM)38.10m
- Net income in HKD39.17m
- Incorporated2002
- Employees49.00
- LocationMeilleure Health International Industry Group LtdUnit 2906, Tower 1, Lippo Centre89 QueenswayAdmiralty Hong KongHKG
- Phone+852 25631500
- Fax+852 25631900
- Websitehttp://www.meilleure.com.cn
More ▼
Mergers & acquisitions
| Acquired company | 2327:HKG since announced | Transaction value |
|---|---|---|
| Jiangsu Yide Investment Co Ltd | -5.36% | 17.83m |
Data delayed at least 15 minutes, as of Feb 16 2026 03:57 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhongzhi Pharmaceutical Holdings Ltd | 2.27bn | 23.25m | 630.43m | 2.49k | 26.49 | 0.5132 | 4.38 | 0.2777 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 881,008.10 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 686.69m | 504.00 | 7.55 | 1.79 | 6.00 | 1.16 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Fusen Pharmaceutical Co Ltd | 272.64m | -197.95m | 687.55m | 1.05k | -- | 1.75 | -- | 2.52 | -0.2678 | -0.2678 | 0.3688 | 0.5303 | 0.1875 | 1.11 | 4.05 | 241,059.40 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Pak Fah Yeow International Ltd | 199.03m | 70.97m | 741.70m | 100.00 | 10.45 | 1.05 | 9.56 | 3.73 | 0.2277 | 0.2277 | 0.6386 | 2.26 | 0.2227 | 1.84 | 24.74 | 1,877,594.00 | 7.94 | 5.03 | 8.68 | 5.24 | 87.44 | 82.23 | 35.66 | 23.92 | 6.21 | 7.72 | 0.0068 | 94.02 | -8.64 | 9.89 | -25.14 | 16.88 | 16.37 | -8.84 |
| Modern Chinese Medicine Group Co Ltd | 228.75m | 21.47m | 813.60m | 190.00 | 31.58 | 1.23 | 23.38 | 3.56 | 0.0358 | 0.0358 | 0.3813 | 0.9155 | 0.392 | 5.89 | 7.49 | 1,203,966.00 | 3.68 | 14.83 | 3.93 | 17.56 | 24.57 | 38.44 | 9.38 | 17.92 | 7.80 | 21.30 | 0.0003 | 2.85 | -37.78 | -0.4333 | -80.18 | -26.87 | 112.81 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.44bn | 97.81m | 871.48m | 1.04k | 8.91 | 0.4484 | 4.33 | 0.6067 | 0.1661 | 0.1661 | 2.44 | 3.30 | 0.5181 | 2.64 | 9.17 | 1,405,524.00 | 2.32 | 13.85 | 2.99 | 18.24 | 53.10 | 59.37 | 4.48 | 35.22 | 0.7111 | 7.99 | 0.1179 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| 3D Medicines Inc | 507.27m | -190.63m | 1.05bn | 183.00 | -- | 1.29 | -- | 2.06 | -0.7781 | -0.7781 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,655,869.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Transcenta Holding Ltd | 10.64m | -301.33m | 1.05bn | 171.00 | -- | 1.30 | -- | 98.49 | -0.7437 | -0.7437 | 0.0263 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,844.45 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 1.08bn | 49.00 | 27.60 | 0.8898 | -- | 28.44 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 207.00m | 1.13bn | 798.00 | 5.47 | 0.5774 | 4.71 | 1.08 | 0.3695 | 0.3695 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,407,584.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.37bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Meilleure Health International Industry Group Ltd's reporting currency: Hong Kong Dollar HKD
0.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 1.25m | 0.03% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 140.40k | 0.00% |
| DFA Australia Ltd.as of 30 Nov 2025 | 2.90k | 0.00% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
